Partners Capital Investment Group LLP purchased a new position in Synopsys, Inc. (NASDAQ:SNPS – Free Report) in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 49,196 shares of the semiconductor company’s stock, valued at approximately $36,738,000. Synopsys accounts for 1.3% of Partners Capital Investment Group LLP’s portfolio, making the stock its 19th biggest position.
A number of other large investors have also added to or reduced their stakes in SNPS. Sankala Group LLC bought a new position in Synopsys in the fourth quarter valued at about $25,000. Elevation Wealth Partners LLC grew its stake in shares of Synopsys by 96.4% during the 2nd quarter. Elevation Wealth Partners LLC now owns 55 shares of the semiconductor company’s stock valued at $25,000 after purchasing an additional 27 shares during the period. Osbon Capital Management LLC purchased a new stake in shares of Synopsys during the 2nd quarter valued at about $25,000. IMG Wealth Management Inc. bought a new position in shares of Synopsys in the 2nd quarter worth approximately $28,000. Finally, Caitong International Asset Management Co. Ltd bought a new position in shares of Synopsys in the 4th quarter worth approximately $28,000. Institutional investors own 85.47% of the company’s stock.
Synopsys Price Performance
NASDAQ SNPS opened at $394.51 on Tuesday. The company has a current ratio of 1.43, a quick ratio of 1.32 and a debt-to-equity ratio of 0.33. Synopsys, Inc. has a 12 month low of $366.00 and a 12 month high of $615.79. The stock has a market cap of $75.54 billion, a price-to-earnings ratio of 91.32, a PEG ratio of 2.34 and a beta of 1.23. The company’s 50 day moving average is $418.53 and its two-hundred day moving average is $439.92.
Analyst Ratings Changes
SNPS has been the subject of several recent research reports. Benchmark restated a “buy” rating on shares of Synopsys in a research report on Wednesday, August 19th. Stifel Nicolaus increased their price target on shares of Synopsys from $550.00 to $600.00 and gave the stock a “buy” rating in a research report on Thursday, May 28th. Wells Fargo & Company dropped their price target on shares of Synopsys from $535.00 to $450.00 and set an “equal weight” rating on the stock in a research note on Tuesday, August 11th. KeyCorp reissued an “overweight” rating on shares of Synopsys in a research report on Wednesday, August 19th. Finally, Rosenblatt Securities upped their price objective on Synopsys from $530.00 to $575.00 and gave the stock a “buy” rating in a research note on Tuesday, May 26th. One research analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, Synopsys has a consensus rating of “Moderate Buy” and an average price target of $563.59.
View Our Latest Report on Synopsys
Insider Activity
In other Synopsys news, CFO Shelagh Glaser sold 3,394 shares of the company’s stock in a transaction that occurred on Friday, June 12th. The stock was sold at an average price of $450.02, for a total value of $1,527,367.88. Following the completion of the transaction, the chief financial officer directly owned 14,358 shares in the company, valued at $6,461,387.16. This represents a 19.12% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sassine Ghazi sold 14,603 shares of the stock in a transaction that occurred on Monday, June 15th. The shares were sold at an average price of $458.96, for a total transaction of $6,702,192.88. Following the sale, the chief executive officer directly owned 75,020 shares of the company’s stock, valued at approximately $34,431,179.20. This trade represents a 16.29% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. 0.56% of the stock is owned by insiders.
Synopsys Company Profile
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Featured Articles
- Five stocks we like better than Synopsys
- Visa Just Put Hims & Hers in the Penalty Box—Here’s Why It Matters
- Treasury Yields Are Surging Again: 3 Stocks That Could Feel the Pain
- Snowflake Could Be Headed for New Highs Despite Insider Selling
- MongoDB Is Surging—And the Next Catalyst Is Almost Here
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
